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Abstract 
Pre-exposure prophylaxis (PrEP) is a novel bio-medical HIV prevention option for individuals at 
high risk of HIV acquisition. Although PrEP has yielded encouraging results in various clinical 
trials, opponents argue that PrEP poses a number of risks to human health and to STI prevention 
efforts. Using qualitative thematic analysis and social representation theory, this article explores 
coverage of PrEP in the UK print media between 2008 and 2015 in order to map the emerging 
social representations of this novel HIV prevention strategy. The analysis revealed two 
competing social representations of PrEP: (1) as a positive development in the “battle” against 
HIV (the hope representation) and (2) as a medical, social and psychological setback in this 
battle, particularly for gay/bisexual men (the risk representation). These social representations 
map onto the themes of PrEP as a superlatively positive development; PrEP as a weapon in the 
battle against HIV/AIDS; and risk, uncertainty and fear in relation to PrEP. The hope 
representation focuses on taking (individual and collective) responsibility, while the risk 
representation focuses on attributing (individual and collective) blame. The implications for 
policy and practice are discussed. 
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Polarised Press Reporting about HIV Prevention:  
Social Representations of Pre-Exposure Prophylaxis (PrEP) in the UK Press 
 
Pre-exposure prophylaxis (PrEP) is a novel bio-medical approach for preventing HIV infection. 
The drug Truvada®1 is currently used as PrEP in the US and in clinical trials in the UK. Several 
trials have demonstrated that, if taken correctly, PrEP can block a permanent infection from 
taking hold after HIV has entered the body. Yet, PrEP is not without its controversies – critics 
argue that PrEP poses a number of risks to human health and to STI prevention efforts (Lacor, 
2012). While there has been some attitudinal research into PrEP (Brooks et al., 2012; 
Tangmunkongvorakul et al., 2013), there has been no insight into social representations that are 
emerging in this debate. The print media can play an important role in setting the agenda for 
science and medicine, and can contribute to shaping public perceptions and policy debates. This 
article explores coverage of PrEP in the UK print media between 2008 (when PrEP was first 
mentioned in the UK press) and 2015 in order to map the emerging social representations of this 
novel HIV prevention strategy. 
 
HIV Prevention 
The Human Immunodeficiency Virus (HIV), which causes Acquired Immune Deficiency 
Syndrome (AIDS), has already claimed the lives of approximately 36 million people worldwide 
since the first clinical observations in 1981. It is estimated that in 2014 36.9 million people were 
living with HIV globally.2 In the UK, HIV prevalence is approximately 0.19% of the population 
aged between 15 and 59 – it is estimated that some 103,700 people are living with the virus, 17 
per cent of whom are unaware of their positive serostatus (Public Health England, 2015). Men 
who have sex with men (MSM) suffer major inequalities in relation to HIV. According to Public 
Health England (2015), approximately 45,000 MSM were living with HIV in 2014, and in 
London it is estimated that 1 in 11 MSM did so. In 2014 there were 5850 new diagnosed cases of 
(sexually transmitted) HIV, of which 57% were among MSM. 
In the absence of a vaccine, prevention remains the most effective tool against HIV. 
Condom use has long been the preferred policy strategy in most developed countries. Although 
condoms remain a highly effective STI prevention method, it is clear that not everybody uses 
them consistently (Shernoff, 2006). In addition to condoms, other prevention techniques are used. 
For instance, MSM in particular may engage in ‘serosorting’, that is, they may have 
(condomless) sex with people who they believe share their HIV status (Golden et al., 2008). 
However, many HIV-positive individuals are unaware of their status and, due to the social 
stigma, some may choose not to disclose it. Furthermore, treatment as prevention constitutes an 
effective public health strategy, given that effective antiretroviral therapy (ART) suppresses the 
HIV-infected individual’s viral load to ‘undetectable’ levels, thereby reducing their risk of 
onward transmission (Attia et al., 2009). Nevertheless, many new infections occur as a result of 
sexual intercourse with an HIV-infected individual who is not virally suppressed, either because 
they are unaware of their infection or because they have not yet started ART. In this context, 
rising HIV incidence has led to debates around novel prevention strategies. 
 
The Emergence of PrEP: Opportunities and Risks 
A series of clinical trials such as iPrEx (Grant et al., 2010), Partners PrEP (Baeten et al., 2010) 
and PROUD (McCormack et al., 2016), in which a subgroup of individuals are offered the 
experimental drug Truvada and a control group is offered a placebo drug, have repeatedly 
demonstrated the effectiveness of orally administered PrEP. In 2012 the US Food and Drug 
Administration approved the use of Truvada as PrEP among individuals at high risk of HIV 
acquisition, that is, those in a serodiscordant sexual relationship and those who do not use 
condoms consistently with partners of unknown serostatus.3  
		 3 
This decision has not met with unanimous acceptance. Michael Weinstein, president of the 
AIDS Healthcare Foundation, recently branded PrEP a “party drug” and warned of decreased 
condom use and increased STI incidence.4 Weinstein has since described PrEP as “an individual 
option, not a general solution”.5 Similarly, Richard Weinmayer, a research associate at the 
American Medical Association’s Ethics Group, has claimed that PrEP will induce “sexual 
irresponsibility.”6 There is evidence of social stigma in relation to PrEP users who have been 
branded “Truvada whores” (Spieldenner, in press), which may induce shame and discourage use 
of PrEP. Most health insurance companies in the US at least partially fund PrEP when prescribed 
by a physician but there are some barriers to access (e.g. awareness and cost) (Bauermeister et al., 
2013).  
Uptake of PrEP has been relatively low (Flash et al., 2014), which may be attributed partly 
to the following concerns:  
• PrEP is often positioned as a prevention technique that should be used alongside 
condoms. However, critics have voiced concerns that PrEP may encourage sexual risk-
taking and increase the incidence of other STIs. This reflects concerns regarding condom 
fatigue among MSM (Kalichman et al., 1998).  
• Adherence to PrEP in the way prescribed is central to its effectiveness. Given that drug 
adherence has already been identified as a significant problem in treating HIV-positive 
patients (Fogarty et al., 2001), critics fear poor adherence to PrEP. Recent attitudinal 
research suggests that one’s HIV-negative serostatus may create complacency vis-à-vis 
PrEP adherence (Tangmunkongvorakul et al., 2013). However, it is acknowledged that 
the IPERGAY clinical trial conducted in France and Canada demonstrated that 
intermittent dosing of PrEP (consisting of two Truvada pills taken 2-24 hours before a 
possible exposure, followed by a third pill 24 hours after the possible exposure and a 
fourth pill 48 hours after the possible exposure) is 86% effective (Molina et al., 2015). 
• The clinical trials have found no evidence of serious side effects of using PrEP, although 
minor side effects (e.g. stomach pains and loss of appetite) have been observed in some 
patients. PrEP sceptics fear potential long-term side effects (e.g. decreased kidney 
function). 
• There is evidence of strains of HIV that are becoming resistant to tenofovir, one of the 
drugs in PrEP, which theoretically could compromise the effectiveness of PrEP (The 
TenoRes Study Group, 2016). 
• HIV-positive individuals must never use PrEP because this could lead to future drug 
resistance, thereby limiting treatment options. Critics have highlighted their concern that 
some PrEP users may not have regular HIV tests and may become HIV-positive while 
using PrEP (inconsistently).  
PrEP has not yet been approved in the UK. It has been available free of charge only to MSM 
enrolled in the PROUD study, which is the UK clinical trial of PrEP for use among MSM 
(McCormack et al., 2016). PrEP is not currently available on the UK National Health Service 
(NHS) but prominent UK HIV/AIDS organizations and sexual health charities, such as the 
Terrence Higgins Trust, National AIDS Trust, GMFA and NAZ: Sexual Health for Everyone 
have called for PrEP to be made available on the NHS. In March 2016, NHS England decided 
not to commission PrEP, arguing that commissioning HIV prevention services is the 
responsibility of local authorities. In response to this decision, supporters of PrEP have launched 
a petition calling for PrEP to be made available on the NHS.7 There are reports that some MSM 
are purchasing a generic version of PrEP Tenvir-EM (which contains the same drugs as Truvada) 
online, while others are engaging in “clinic hopping”, that is, they falsely claim to have been at 
risk of HIV and are requesting post-exposure prophylaxis (PEP)8 at several sexual health clinics 
and using one of the drugs (Truvada) as PrEP.  
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Science and Media: The Role of Social Representations 
The media constitute a key source of societal information regarding scientific, technological and 
medical developments, like PrEP (Entman, 1989). When faced with a novel medical issue, the 
media tend to rely on metaphors and commonplace images in order to conceptualise and 
communicate about it. In this study, we draw upon Social Representations Theory (Moscovici, 
1988), which focuses on collective elaborations of knowledge and how cultural meaning systems 
evolve. A social representation consists of a network of ideas, values and practices in relation to 
a given social object. Social representations enable us to understand the novel and unknown 
through two principal social psychological mechanisms - anchoring and objectification: 
• Anchoring refers to the process of making something unfamiliar understandable by 
linking it to something familiar. For instance, by anchoring PrEP to the contraceptive pill, 
PrEP may be normalised and understood primarily in terms of the characteristics of the 
pill.   
• Objectification is the process whereby unfamiliar and abstract objects are transformed 
into concrete and ‘objective’ common-sense realities – most notably through the use of 
metaphor – allowing us to map aspects of more familiar knowledge (the so-called source 
domain) onto more unfamiliar knowledge (the so-called target domain) (Lakoff and 
Johnson, 1980). For instance, the use of war metaphors can serve to construct PrEP as a 
powerful and effective weapon against HIV, thereby fostering positive expectations and 
hopes about its benefits, while metaphors describing PrEP as a ‘party drug’ taken 
recklessly may foster stigma, negative expectations and fear.  
Although alternative theoretical frameworks like metaphor analysis and frame analysis were 
considered, we felt that a broad heuristic framework that could capture frames, metaphors and 
social imagery would be more appropriate. As a relatively novel and unknown medical 
development, PrEP has to be anchored to, and objectified in terms of existing constructs both in 
scientific and popular media. Therefore, Social Representations Theory provides an appropriate 
framework for examining the transition of PrEP from the world of science to the social 
psychological domain. This study stands in a long tradition of work focusing on infectious 
diseases from a social representations and media perspective from Susan Sontag’s (1978, 1989) 
work on AIDS, its metaphors and social stigma to more recent work on infectious disease and 
society (Herek, 1990; Washer, 2010; Eicher & Bangerter, 2015). 
In this article we investigate this anchoring process in “real time” in order to observe 
emerging social representations of risk and benefits, hope and fear, blame and responsibility, 
which might influence both the production and uptake of PrEP. Furthermore, as Breakwell 
(2014) has argued, when social representations enter the social and psychological domain, 
individuals take a stance on them by “personalising” them. Although this exploratory study 
focuses on the print media only, it provides initial insights into the possible ways in which social 
representations of PrEP may become salient and relevant, and be accepted or rejected by people 
who could potentially benefit from PrEP.   
We present a qualitative thematic analysis of the coverage of PrEP in the print media 
until May 2015 (when we conducted our analysis). We focus on the emerging social 
representations of PrEP during this period and scrutinise the contexts in which they appear and 
the functions that they may perform in debate and public understanding. More specifically, we 
examine whether PrEP is depicted positively or negatively, how it is anchored and objectified 
(e.g. which metaphors are used), and the policy responses that are concurrently legitimised.  
However, it is important to acknowledge possible limitations to this approach. PrEP has 
not been a major issue of discussion in UK newspapers. This makes it an ideal case study for a 
small-scale qualitative analysis which attempts to trace the emerging contours of an important 
debate on HIV prevention. The print media constitute an important source of societal 
information regarding health and medicine and can at least set the tone for socio-political 
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engagement with such issues, by influencing and reflecting policy agendas (Reese et al., 2003). 
Representations in the print media are often taken up and reproduced in other socio-political 
contexts like social media platforms. Our exploratory study excludes online discussions which 
are emerging quickly and which will thus need to be studied separately. There is, for example, a 
Facebook page on PrEP with almost 8500 subscribers, paid editorial staff, and a constant and 
lively discussion around the topic. The pharmaceutical industry too uses social media and, in the 
US, the Federal Drugs Administration (FDA) issues guidance on such engagement.9 Future 
studies of PrEP will need to monitor these developments, especially when studying the uptake of 
and debate around PrEP, in the UK, the US and elsewhere. 
 
METHOD 
The Corpus 
Using the keywords “Pre-Exposure Prophylaxis” and “HIV” on the Nexis® news database,10 we 
conducted a search of all UK newspapers and extracted all articles published until 15/04/15 (our 
search date). This yielded a total of 59 newspaper articles, all of which were relevant and 
therefore included in the analysis. The first articles to mention PrEP were published in Metro (a 
daily newspaper distributed for free on public-transport services in UK urban centres) and 
London Lite (a now defunct daily newspaper that was distributed for free in Central London) on 
20 November 2008 and the last appeared in The Independent on 9 April 2015. These outlets 
reflect a wide range of political perspectives and include both national and local newspapers. 
 
Table 1 provides an overview of the distribution of articles included in the analysis: 
 
 
Table 1: Number of articles included in the analysis by outlet 
 
Analytical procedure 
We analysed the corpus using qualitative thematic analysis, which has been described as “a 
method for identifying, analysing and reporting patterns (themes) within data” (Braun & Clarke, 
2006, p. 78). Thematic analysis allowed us to identify emerging social representations of PrEP as 
a socio-medical issue, and the dominant rhetorical strategies used to construct them. 
We read and re-read the articles to familiarise ourselves with the broader themes that we 
subsequently discussed analytically. The left margin of each article was used to note initial 
observations that captured essential qualities, units of meaning and rhetorical techniques. We 
discussed our respective initial codes, which included inter alia general tone, particular forms of 
language, comparisons, categorisations and emerging patterns in the data. These initial codes 
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were collated into preliminary themes, and arranged into a coherent structure that reflected the 
analysis. This process resulted in the identification of three superordinate themes.  
In addition to describing dominant themes in the corpus, we identified linguistic elements, 
especially metaphors that performed the functions of anchoring and objectification. The 
superordinate themes can be considered social representations because they “assume a 
configuration where concepts and images can coexist without any attempt at uniformity, where 
uncertainty as well as misunderstandings are tolerated, so that discussion can go on and thoughts 
circulate” (Moscovici, 1988, p. 233). Thus, the hope and risk representations described in this 
article, collectively, constitute a “framework” for understanding and discussing potentially 
“divergent concepts, inconsistent ideas and paradoxical meanings” in relation to PrEP (Rose et 
al., 1995, p.4).  In the analysis below, we provide extracts from the articles that exemplify the 
superordinate themes. 
 
ANALYSIS 
 
There were two competing social representations of PrEP: (1) as a positive development in the “battle” 
against HIV (the hope representation) and (2) as a medical, social and psychological setback in this 
“battle”, particularly for gay/bisexual men (the risk representation). These social representations map 
onto the themes of PrEP as a superlatively positive development; PrEP as a weapon in the battle 
against HIV/AIDS; and risk, uncertainty and fear in relation to PrEP.  
 
The hope representation 
PrEP was constructed as a key development in HIV prevention in the articles examined. Truvada as 
PrEP was described metaphorically as a “revolution,” “revolutionary,” a “wonder drug,” “game 
changer,” and “the key”. These metaphors collectively construct dramatic positive change in a 
decades’ old pandemic that continues to affect millions, thereby evoking optimism concerning PrEP. 
This ‘breakthrough’ motive is a staple of promissory discourses employed to create positive 
expectations which foster financial and emotional investment (Brown, 2003). 
Articles discussing the results of the iPrEx clinical trial in the US claimed that “[t]his 
discovery alters the HIV prevention landscape forever,”11 that “Truvada has already made history,”12 
and that it was “the most significant breakthrough against the [HIV] virus in a generation.”13 These 
extracts exemplify the social representation of PrEP as irreversibly altering the set of prevention 
options currently available and, thus, providing hope. Moreover, PrEP was constructed as superior to 
the existing prevention methods. The success of PrEP was anchored to Truvada as a treatment option, 
which served to generalise the benefits of Truvada as treatment to Truvada as PrEP. The importance 
of PrEP was presented in hyperbolic terms, that is, as “the most significant breakthrough,” which 
elevated the importance of PrEP over and beyond HIV treatment. Although the wide range of 
treatment options now available to HIV-positive patients, including the one-pill-a-day regimens that 
obviate the serious problem of low adherence, may plausibly be regarded as a vital “breakthrough” 
against HIV, PrEP was consistently constructed as surpassing these developments. Reference to the 
time scale of “a generation” implied that PrEP was the best prevention tool since condoms. Some 
articles appeared to celebrate the novelty of PrEP, rather than its feasibility per se, as highlighted in 
the remark that PrEP “was welcomed as a novel approach to HIV prevention.”14 This signaled a 
shifting of the HIV debate from treatment to biomedical prevention, as opposed to prevention 
through condom use. 
 There is now robust evidence that offering treatment to HIV-positive individuals early, that is, 
while their CD4 count is still relatively high, has both personal health benefits in the long-term, such 
as reducing the risk of serious opportunistic infections (SMART Study Group, 2008) and public 
health benefits because ART significantly reduces the patient’s viral load to “undetectable” levels 
which in turn lowers the risk of onward HIV transmission (Rodger et al., 2014). One article explicitly 
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claimed that PrEP “will be better than treatment as prevention.”15 This tapped into the counter-
argument that most new infections occur through sexual intercourse with a HIV-infected individual 
who is not virally suppressed because they have not yet initiated ART. Consequently, it was argued 
that PrEP gives agency to the HIV-negative individual. As in most articles in favor of PrEP, 
hyperbolic statements were made regarding the contribution of PrEP to mitigating HIV incidence – 
one article noted that “[t]he exciting opportunity that this [PrEP] offers is to make the biggest dent in 
the epidemic of all time.”16 The contribution of previous campaigns, initiatives and medical 
developments were attenuated in order to emphasise the importance of PrEP.  
The language employed to describe the effect that PrEP may have on HIV prevention further 
highlighted the optimism surrounding it, as demonstrated in one article that claimed that the results of 
the PROUD clinical trial “show there is a need for PrEP, and offer hope of reversing the epidemic 
among men who have sex with men in this country [the UK].”17 Thus, there was an emerging social 
representation that PrEP might not only prevent HIV but actively reverse and dent it, particularly 
among gay/bisexual men. Several newspaper headlines read “HIV drug a game changer, says expert,” 
and the metaphor “game-changer” was used in relation to both the clinical trial and PrEP as a 
prevention tool.18 Thus, the metaphors of positive change and the comparisons between PrEP and 
existing prevention tools contributed to the hope representation. 
 Consistent with the hope representation of PrEP, many articles focused on the need to make 
PrEP available to HIV-negative individuals at risk of HIV exposure. For instance, having described 
PrEP through a journey metaphor as a “massive step in the right direction” in terms of HIV 
prevention, Professor Sheena McCormack of the Medical Research Council clinical trials unit at 
University College London, who was also the lead investigator in the PROUD study, was quoted as 
saying that “[t]he priority now is getting the guys back into the clinic to offer PrEP”19 and, in a sense, 
send them on a better life journey. Here reference was being made to the realisation among the 
research team that PrEP provided excellent protection against HIV and that they should offer PrEP to 
the control group taking a placebo. This laid the rhetorical foundations for arguing in favor of making 
PrEP widely available, as observed in a commentary in The Guardian that pondered “Can a new drug 
help to end 30 years of blighted lives?” and affirmatively argued that “[a]n anti-HIV medicine giving 
peace of mind to gay men in the US should be offered here on the NHS.”20 This commentary began 
by highlighting the devastating effect of HIV/AIDS on gay/bisexual communities around the world – 
metaphorically referred to as “blighted lives”, thus evoking imagery of injury, pain and devastation, 
which PrEP could prevent. The commentary proceeded to acknowledge both the potential physical 
and psychological benefits of PrEP, that is, as an HIV prevention tool but also as one that might 
facilitate psychological wellbeing among gay/bisexual men who for decades have lived in fear of 
HIV. This acknowledged the long-standing anxiety surrounding HIV infection among gay/ bisexual 
men (Shernoff, 2006). 
Several articles juxtaposed positive imagery of PrEP and the possibility that it might be 
offered by the NHS, as suggested in the headlines “‘Wonder drug’ which can reduce HIV risk by 
92% could be offered on the NHS”21 and “Pressure grows on NHS to make new HIV wonder drug 
available for those at risk.”22 The metaphor “wonder drug” emphasised the positive imagery of 
novelty and confidence about the efficacy of PrEP in HIV prevention, differentiating it favourably 
from other prevention tools. The tentative observations that it “could” be offered on the NHS and that 
there was “pressure” for it to be offered introduced this possibility in the debate and, in juxtaposition 
with the positive imagery of PrEP, constructed its endorsement by the NHS as a logical step forward. 
In some articles, this was presented more forcefully – “HIV pill Truvada that cuts risk of infection 
among gay men by 86% needs to be available on the NHS as soon as possible.”23 
The social representation of Truvada as a ‘wonder drug’ can be compared to the metaphor of 
the ‘silver bullet’ in other discourses focusing on ‘fighting’ infectious diseases (Koteyko et al., 2008). 
Following Breakwell’s (2014) model of personalising representations, the salience of the hope 
representation may plausibly promote awareness and acceptance of PrEP as a highly effective HIV 
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prevention method, particularly among gay/bisexual men given the focus on this group in the 
coverage. However, there was little consideration of its mechanisms (i.e. how PrEP works) or the 
possible risks associated with it, which may not be conducive to an adequate understanding of the 
representation. In the following section, we focus on an important aspect of the hope representation, 
namely the use of militaristic metaphors which are a well-established rhetorical resource when 
talking about AIDS (Waldby, 1995).  
 
PrEP as a weapon in the battle against HIV/AIDS 
War-related metaphors were employed to render salient and reinforce the hope representation; PrEP 
was depicted as a weapon in the battle against HIV/AIDS. There was much optimism in reporting on 
PrEP and its future role in HIV prevention - it was noted that PrEP is expected “to significantly 
increase the momentum in our fight against the virus.”24 The context of HIV prevention was 
constructed metaphorically as a battlefield and HIV as winning the battle before the advent of PrEP. 
One article described PrEP in the context of the “AIDS battle,”25 while in others PrEP was identified 
as “the most significant breakthrough in the battle against the [HIV] virus in a generation”26 and as a 
“breakthrough in [the] battle against [the] global scourge.”27 Another article stated that the “US 
approves pill that guards against HIV […] potentially offering a new and powerful weapon in the 
battle against AIDS”28 Use of the verb “to guard against” again evoked imagery of military 
protection, which was further reinforced through use of another war metaphor “weapon.” More 
specifically, PrEP was being characterised not only as a weapon but as a “new and powerful” one. 
Thus, it provided renewed hope against a virus that has hitherto been characterised as invincible. 
Despite the constructed power of PrEP, it was represented as gentle to human beings, which is quite 
different from social representation of ART as causing serious side effects (Bauermeister et al., 2013). 
In one article, for example, it was claimed that PrEP “offers a safety net” for individuals at risk.29  
The war framing constructed a very optimistic representation of PrEP, as demonstrated in a 
commentary piece for The Guardian in which it was referred to as “a powerful addition to the 
arsenal of weapons against the increasingly besieged HIV virus.”30 HIV was depicted as being 
surrounded militarily by external forces compelling its surrender, which referred to the plethora of 
prevention and treatment options already available (that is, the existing “arsenal of weapons”). 
Furthermore, it was PrEP in particular that was represented as bringing about a decisive victory in the 
“battle” against HIV. As discussed above, the role of Truvada as PrEP in HIV prevention was 
depicted as uniquely important – “Modern anti-retrovirals are phenomenally potent weapons and they 
could be the key to finally halting the epidemic.”31 As in this extract, there was widespread use of 
war metaphors, qualified by superlative adjectives (here “phenomenally potent”) in order to 
accentuate the force of PrEP in HIV prevention and, thus, its centrality to “halting the epidemic”, 
another use of a journey metaphor but one focusing on ending rather than starting a journey. 
 Previous research into representations of infectious disease, such as Foot and Mouth Disease 
(Nerlich et al., 2002) found that war metaphors dominated discourse and policy, sidelining policies 
such as vaccination. However, the search for a vaccine has been key in HIV research. In several 
articles, PrEP was actively anchored to vaccination, which provided a lens for viewing and 
evaluating the prevention tool. One article, which focused on the results of a European clinical trial, 
noted that “[p]rotection of 96 to 100% is better than even the best vaccine.”32 Here, PrEP was being 
evaluated from the perspective of a vaccine. More specifically, it was depicted as being superior to a 
vaccine, thereby accentuating the positivity and efficacy of PrEP as a “powerful HIV prevention 
tool.”33 Furthermore, that article speculated that by encouraging the use of PrEP among “enough 
inhabitants, the whole viral load of a city can be lowered. That protects everyone – just as vaccination 
could protect whole communities from smallpox.”34 PrEP was, thus, anchored to the general notion 
of vaccination and implied to function in a similar way. It was explicitly anchored to smallpox, which 
was successfully eradicated due to the introduction of a vaccine. This created an optimistic lens 
through which to view the potential effects of PrEP on the HIV epidemic. In considering the 
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personalisation of the hope representation of PrEP (consisting of its military metaphors) (Breakwell, 
2014), it can be argued that the coverage promotes an understanding of PrEP as a highly effective 
tool capable of eradicating HIV, which in turn is relegated to a victimhood position. Individuals may 
plausibly activate mental imagery of vaccination in thinking about the prevention tool. However, 
despite this positive imagery, the hope representation competed with an emerging risk representation. 
 
The risk representation 
There was a competing negative social representation of PrEP which emphasised uncertainties and 
risks associated with this biomedical option. In contrast to the social representation of breakthrough 
and hope that focuses on heroes who try to win the fight against a villainous virus, this is primarily a 
social representation of fear and stigma, where the heroes are recast as villains and the virus emerges 
as potentially victorious. To encourage acceptance of this representation (Breakwell, 2014), a series 
of reasons for dismissing PrEP were highlighted in numerous articles, most notably doubts 
surrounding medication adherence, the effectiveness of PrEP, potential side effects and increased 
sexual risk-taking. 
Several articles pointed to a false sense of hope, which raised questions about the 
effectiveness of PrEP, thereby challenging the hope representation. One article noted that the 
approval of PrEP was “given a cautious welcome, but with some experts arguing that it could lead to 
a false sense of security.”35 The invocation of caution served to challenge the competing hope 
representation because it introduced the possibility of negativity and risk, which were often 
understated in pro-PrEP articles. Some articles challenged the growing representation of unanimous 
endorsement of PrEP in the HIV/AIDS community. This highlighted the uncertainties underpinning 
PrEP vis-à-vis other prevention tools (e.g. condoms). Several articles reiterated that “PrEP does not 
work all the time, nor does it prevent sexually transmitted infections like syphilis and gonorrhea.”36 
In direct contrast to the hope representation, there was an emerging counter-representation that PrEP 
was inconsistent in inhibiting HIV infection and completely ineffective in inhibiting other STIs, 
which reaffirmed the centrality of condoms in HIV prevention. The contestation of positive 
representations of PrEP constitutes a means of encouraging acceptance of the negative representation 
of it (Breakwell, 2014). 
In addition to questioning the effectiveness of PrEP, many articles pointed to “fears [that] 
some people would pop a pill and then refuse to worry about contraception,”37 a reference to condom 
use. The statement that individuals might “pop a pill” suggested that PrEP would be taken blithely 
with no guarantees about its effectiveness. This specific construction anchored PrEP implicitly to 
illicit substance abuse, which is the context in which “pop a pill” tends to be employed. This served 
to anchor potential users of PrEP to drug users, which was particularly important in view of the fact 
that PrEP would be taken by healthy individuals. Indeed, this was echoed in another article in which 
PrEP was described as a “party drug” (discussed below). More generally, this risk representation 
constructed individuals who may benefit from PrEP (e.g. gay/bisexual men) as paradoxically 
undermining efforts to prevent HIV infection due to their “party” behaviour. 
An important strand of uncertainty concerned the sexual risk behaviors of potential PrEP 
users. In particular, it was argued that PrEP users would cease to use condoms, which evoked the 
long-standing perception of “condom fatigue” in the gay/bisexual male community (Shernoff, 2006). 
Condom abandonment was presented as problematic, as preliminary clinical trials suggest that PrEP 
is not 100% effective and because it provides protection against HIV infection only and not against 
other STIs. One article noted that “some critics in the US have warned that the drug could lead to a 
complacency around condom use and more unsafe sexual behavior” and that there would be an 
“increase in risk-taking behavior.”38 It claimed that sexual risk-taking might paradoxically “outweigh 
the prevention effectiveness of Truvada.”39 These statements served to introduce the (risk) 
representation of sexual complacency, which undermined a key premise of PrEP that most agree on, 
namely the need for concurrent use of condoms. 
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Pro-PrEP articles cited evidence from clinical trials that PrEP did not decrease condom use in 
their population sample. However, many articles questioned this emerging evidence. For instance, 
one article observed that the study “did not prove it unequivocally.”40 Thus, the lack of certainty was 
presented as cause for scepticism. Another article described the emerging concern among critics that 
PrEP “will lead to men being more promiscuous or having riskier sex without condoms in the 
knowledge they were protected from the illness.”41 This tapped into an existing social representation 
that gay/bisexual men are necessarily promiscuous and prone to engaging in “riskier sex” (Shernoff, 
2006). Indeed, this emerging risk representation was reinforced in articles in which generalisations 
were made about gay/bisexual men’s sexual behaviors. One article stated that “[m]en generally hate 
condoms. Their partners usually give in. Almost no one abstains. Precious few stay faithful.”42 
Although this article was largely in favor of exploring the use of PrEP among high-risk groups, the 
social representation of sexual promiscuity among gay/bisexual men contributed to the overarching 
fear of increased sexual risk-taking. By constructing gay/bisexual men as averse to monogamy and 
condom use, this article served to represent PrEP as possibly accentuating these “problems” in 
gay/bisexual men. 
Prominent figures in the LGBT and HIV communities were quoted in relation to risk 
reporting, and strategic expert quoting was employed to construct PrEP as a threat. One article noted 
that “[s]ome experts remain concerned that PrEP will do more harm than good43. There was some 
media coverage of similar remarks made by prominent gay actor Zachary Quinto. Several articles 
quoted him as referring to “tremendous complacency” and “laziness” among gay/bisexual men in 
relation to safer sex practices.44 He reportedly stated that “AIDS has lost the edge of horror it 
possessed when it swept through the world in the ‘80s. Today’s generation sees it more as something 
to live with and something to be much less fearful of. And that comes with a sense of, dare I say, 
laziness.” Quinto framed PrEP as an “insurance policy against […] unprotected non-monogamous 
sex” which he also called “recreational sex.” Quinto, a sexual ingroup member, was himself 
represented as opposing PrEP on the grounds that it would increase condomless sexual promiscuity, 
which could severely challenge the effectiveness of PrEP. The metaphor “insurance policy” and the 
euphemism of “recreational sex” (for promiscuous sex) constructed PrEP as a threatening pathway to 
increased sexual risk-taking.  
Similarly, Weinstein, the president of the AIDS Healthcare Foundation in the US was quoted 
as referring to Truvada as a “party drug” which would lead to sexual risk-taking.45 This extract 
anchored PrEP to drug use among gay/bisexual men in sexualised settings, commonly referred to as 
“chemsex.” This itself has been linked to rising HIV incidence in these groups (Bourne et al., 2014). 
Sexual risk-taking among gay/bisexual men was framed in intergroup terms in the UK media’s 
discussions concerning the possible availability of PrEP in the UK, which raised concerns about the 
potential financial implications for the NHS. While one article questioned the “logic of paying £500 a 
month so gay men don’t have to wear condoms” in the context of a cash-strapped NHS, another 
article’s headline read: “Why should WE pay for gays to have unsafe sex?”46 The article described 
hypothetical scenarios of individuals suffering from cancer and the lack of funding for cancer 
medication. This positioned PrEP in competition with cancer treatment. These articles constructed 
rigid intergroup boundaries between the gay/bisexual outgroup, depicted as inherent risk-takers, and 
the “responsible” (presumably heterosexual) ingroup. PrEP was implicitly positioned as replacing 
cancer treatment and, thus, as posing a risk not only to HIV-negative individuals but also to cancer 
patients. 
Given these severe criticisms, there was emerging opposition to PrEP. Weinstein was again 
quoted as referring to the decision by the US Food and Drug Admission (FDA) to approve PrEP as 
“completely reckless and a move that will ultimately set back years of HIV prevention efforts” and as 
a move that is “negligence bordering the equivalence of malpractice which will sadly result in new 
infections, resistance and serious side effects among many, many people.” Use of the terms “reckless,” 
“negligence” and “malpractice” by the president of a prominent Los Angeles-based AIDS charity 
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gave credibility to the notion that the FDA had hastily and unprofessionally taken a decision that 
would damage HIV prevention efforts. This cast severe doubt on the trustworthiness of the federal 
agency and on its ability to protect citizens, thereby decreasing the credibility of the social 
representations (of PrEP) it endorses and disseminates. Contrary to the hope representation, 
introduction of the drug was actively represented as harming HIV prevention efforts, thereby 
bolstering the risk representation. Following Breakwell’s (2014) model of personalising 
representations, it can be argued that these articles promote salience and awareness of the risk 
representation (drawing on threat and uncertainty) and encourage an understanding of this 
representation based on complacency, promiscuity and sexual risk-taking.  
 
 
DISCUSSION 
 
This article examines emerging social representations of PrEP in the UK press between 2008 and 
2015, and develops some speculative hypotheses about possible public responses to them (Breakwell, 
2014). The print media make an important contribution to social representations because, collectively, 
they constitute “a forum for the discourses of others and [are] a speaker in their own right” (Carvalho, 
2007, p. 224). They provide space for notions, images and theories to become popularised in the 
cultures and minds of individuals. The UK newspaper press was ambivalent in its evaluation of PrEP 
and contributed to both positive and negative social representations of the drug. To this extent, it is 
appropriate to consider the UK press reporting as highly polarised – as either highly positive or 
highly negative. Overall, the coverage of PrEP appeared to centre around two major social 
representations: 
• The hope representation accentuates the positive characteristics of PrEP as an HIV 
prevention method and positions it as superior to existing methods. Through the use of war-
related metaphors, PrEP is positioned as decisively changing the course of HIV prevention. 
As indicated in Borup et al.’s (2006) work on the sociology of expectations in science and 
technology, the hope representation can “guide activities, provide structure and legitimation, 
attract interest and foster investment” in relation to the object of discussion (p. 285-86). 
• The risk representation focuses on the risks and uncertainties associated with PrEP, and 
positions PrEP as a hazard. Through the process of anchoring and objectification, the risks 
associated with it are rendered familiar and located in a common sense system of meaning 
(Barnett & Vasileiou, 2014). As the antithesis of the hope representation, the risk 
representation is intended to delegitimise PrEP and to discourage interest and investment in it. 
More generally, the hope representation focuses on taking (individual and collective) responsibility, 
while the risk representation focuses on attributing (individual and collective) blame. 
In order to substantiate the hope representation, articles described PrEP as a superlatively 
positive development in the campaign against HIV/AIDS through the use of metaphors of positive 
change and revolution, such as “game changer”, “wonder drug” and “revolutionary.” Extreme case 
formulations (Pomerantz, 1986) were employed to emphasise the superiority of this prevention 
method over and beyond existing methods, especially condoms and treatment as prevention. PrEP 
was constructed as a novel, distinctive and highly effective prevention method that ought to occupy a 
preeminent position in HIV prevention. An important rhetorical strategy for constructing the hope 
representation was undoubtedly the consistent use of war-related metaphors in reporting on how 
PrEP might halt the HIV/AIDS epidemic. Fundamentally, PrEP was constructed as a weapon - and a 
very potent one at that - against HIV, which was conversely depicted as besieged in view of this 
biomedical development. This militaristic strand of the hope representation was further bolstered 
through the anchoring of PrEP to vaccination – the ultimate “weapon” in previous epidemics that 
have since been confined to medical history.  
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The hope representation hinges upon the triumph of science and the defeat of the virus. HIV 
was personified as a powerful and evil belligerent that for too long has wreaked devastation on 
humanity, particularly gay/bisexual men, but which, with the advent of PrEP, would be rendered 
powerless. This social representation centred around defeating the virus, as has been the case in 
media reporting on the fight against other emerging infectious diseases such as SARS (Wallis et al., 
2005). Crucially, triumph over the virus was constructed as possible through collective efforts. 
Scientists were positioned as having made significant advances in creating a panacea, drug 
companies in distributing this panacea, and the NHS was positioned as the final “link” in enabling 
PrEP to work, that is, by funding provision. The hope representation implicitly assumes that 
individuals will take responsibility over their sexual health, take their medication regularly and 
continue to use condoms. 
The hope representation competed with a risk representation, which engendered doubts about 
PrEP by scientific uncertainty as well as risks to human health. This social representation generally 
questioned the effectiveness of PrEP - not the science but rather the sexual attitudes and behaviours 
of potential PrEP users. More specifically, the at-risk individual was constructed as inherently 
irresponsible, lazy, complacent, naïve and incompetent. This was depicted as a consequence of their 
(sexual) group membership through anchoring to stereotypical images of gay lifestyle (that is, as one 
characterised by promiscuity and sexual risk-taking). The individual who in principle might benefit 
from PrEP was simply positioned as unable to contribute to the collective efforts required to prevent 
HIV.  
Furthermore, PrEP was represented as increasing sexual risk-taking among gay/bisexual men 
(see Hilton et al., 2010 for a similar representation in relation to HPV vaccination among girls). 
Intergroup dynamics were mobilised primarily on the grounds of sexual orientation. Gay/bisexual 
men were identified as the sole beneficiaries of PrEP and there was little acknowledgement of the 
other groups that might benefit from it, such as heterosexual serodiscordant couples, and intravenous 
drug users. Indeed, PrEP was primarily constructed as a gay/bisexual HIV prevention method. Given 
this emphasis on gay sexuality in negative press reporting, there was also a moralising discourse that 
drew heavily on the stigma of gay sexuality as inherently problematic in a heteronormative world. 
The notion that PrEP might impede other life-saving treatments (e.g. drugs to treat cancer), which, 
conversely, were positioned as benefiting the general population, was made to appear unacceptable. 
PrEP was depicted as taking away vital resources from “us” and, thus, as a threat (Stephan & Stephan, 
2000). This is also consistent with the long-standing association of HIV with the “Other” which has 
long served to distance risk from one’s own identity (Washer, 2010). In short, gay/bisexual men’s 
sexual attitudes and behaviours were constructed as endangering themselves but also others, thereby 
decreasing the effectiveness of PrEP. While the hope representation celebrates the triumph of science 
and defeat of the virus, the risk representation predicts the defeat of science due to the inertia of the 
(gay/bisexual) users of PrEP. 
The risk representation was further supported through direct efforts to subvert the hope 
representation. Some articles represented the hope representation as a red herring by constructing a 
false sense of hope. At a basic level, there was much scepticism about the ability of gay/bisexual men 
to sustain condom use, although there was no evidence of greater sexual risk-taking in the clinical 
trials. Furthermore, the metaphor of “popping a pill” constructed a blithe disregard for sexual health. 
While PrEP was often represented as surpassing condoms, the risk representation firmly reaffirmed 
the position of condoms as the preeminent prevention tool. In addition to the uncertainty surrounding 
sustained condom use, some doubt was cast on users’ ability to adhere to PrEP which could provide a 
“false” sense of protection and, thus, increase risk of HIV infection. Incidentally, these concerns have 
also been mirrored in the findings of existing qualitative interview-based research on PrEP 
(Tangmunkongvorakul et al., 2013).  
Media sociologist Conrad (1997, p. 140) notes that “how we frame a problem often includes 
what range of solutions we see as possible.” There is therefore a need to examine the broader social 
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and psychological ramifications of the emerging debates surrounding PrEP in the UK. As Nerlich et 
al. (2002) have shown with respect to Foot and Mouth Disease, metaphors and narratives have 
important consequences for how emerging problems are perceived and managed. War and battle 
metaphors often encourage the perception that this is a battle of good against evil and that good must 
and will eventually prevail over evil. While the hope and risk representations have a common enemy 
– HIV, they focus on distinct adversaries and sketch out different pathways for policy and behaviour. 
The hope representation focuses on the virus as the main adversary and emphasises the collective 
human struggle against it. The menacing images used to depict PrEP in some articles are downplayed 
in favour of a united front (Wagner et al., 2002). Conversely, the risk representation appeared to 
position gay/bisexual sexual risk-takers as the main obstacle in the effectiveness of PrEP and, thus, as 
endangering themselves and others. The militaristic language added a sense of urgency to deal with 
these adversaries, either by accepting or rejecting PrEP. The hope representation constructs 
endorsement of PrEP as necessary and urgent, while the risk representation depicts its endorsement 
as dangerously irresponsible. 
It is important to have a balanced and informed debate about the feasibility of offering PrEP 
to individuals at high risk of HIV infection. The images, metaphors and social representations that are 
used in this debate must be carefully selected. If chosen unwisely, they may end up stigmatising the 
very groups whom PrEP is intended to protect, thereby accentuating the gulf between groups and 
silencing discourse around sexual health and sexual risk. This may inadvertently contribute to rising 
HIV incidence. Polarised reporting is unlikely to benefit HIV prevention efforts. While the hope 
representation alone may create unrealistic expectations about the ability of PrEP to reduce HIV 
incidence, the risk representation may serve to decrease public and institutional support for PrEP and, 
due to the stigma it engenders, inhibit access to PrEP among those who could benefit from it.  
The print media play an important role in the formation of social representations of PrEP, but 
representations are also co-constructed, contested or supported through other types of communication 
– political rhetoric, literature, education, everyday talk, online discussions and so on. It is therefore 
important that future research engage with discussions concerning PrEP in other social domains, such 
as on social media platforms and fora, in policy debates and in everyday discourse. Individuals who 
could benefit from PrEP must take a stance on the emerging social representations – the extent to 
which they are aware of, understand and accept these representations will be determined by social 
and psychological factors that require empirical attention in the future (Breakwell, 2014). Indeed, 
there is a dynamic interplay between representations, identities and personal experiences. Although 
the data presented in this article exhibit only one small facet of the story regarding social 
representations of PrEP, we argue that this is an important facet – one that can perform an agenda-
setting function and introduce representations that are later taken up in societal debates about HIV 
prevention.  
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